Jennison Associates LLC Novo Nordisk A S Transaction History

Jennison Associates LLC

  • $141 Billion
  • Q1 2025

A detailed history of Jennison Associates LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Jennison Associates LLC holds 18,822,002 shares of NVO stock, worth $1.26 Billion. This represents 0.93% of its overall portfolio holdings.

Number of Shares
18,822,002
Previous 19,944,809 5.63%
Holding current value
$1.26 Billion
Previous $1.72 Billion 23.82%
% of portfolio
0.93%
Previous 1.06%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 02, 2025
SELL
$69.3 - $90.95 $77.8 Million - $102 Million
-1,122,807 Reduced 5.63%
18,822,002 $1.31 Billion
Q4 2024

Jan 24, 2025
SELL
$85.0 - $120.04 $21.3 Million - $30.1 Million
-251,148 Reduced 1.24%
19,944,809 $1.72 Billion
Q3 2024

Nov 08, 2024
SELL
$119.07 - $145.42 $122 Million - $149 Million
-1,024,684 Reduced 4.83%
20,195,957 $2.4 Billion
Q2 2024

Aug 05, 2024
BUY
$122.71 - $146.91 $16.7 Million - $20 Million
136,027 Added 0.65%
21,220,641 $3.03 Billion
Q1 2024

May 02, 2024
SELL
$102.11 - $135.92 $147 Million - $196 Million
-1,443,158 Reduced 6.41%
21,084,614 $2.71 Billion
Q4 2023

Feb 01, 2024
SELL
$87.78 - $105.45 $78.3 Million - $94 Million
-891,633 Reduced 3.81%
22,527,772 $2.33 Billion
Q3 2023

Oct 31, 2023
BUY
$90.94 - $199.54 $1.07 Billion - $2.34 Billion
11,727,507 Added 100.3%
23,419,405 $2.13 Billion
Q2 2023

Aug 03, 2023
SELL
$155.98 - $172.65 $101 Million - $112 Million
-649,563 Reduced 5.26%
11,691,898 $1.89 Billion
Q1 2023

Apr 26, 2023
BUY
$132.34 - $159.14 $117 Million - $141 Million
886,679 Added 7.74%
12,341,461 $1.96 Billion
Q4 2022

Feb 09, 2023
BUY
$102.55 - $135.33 $53.8 Million - $71 Million
524,276 Added 4.8%
11,454,782 $1.55 Billion
Q3 2022

Nov 01, 2022
BUY
$95.28 - $116.93 $39.4 Million - $48.3 Million
413,285 Added 3.93%
10,930,506 $1.09 Billion
Q2 2022

Aug 02, 2022
BUY
$103.24 - $121.81 $515 Million - $608 Million
4,989,744 Added 90.27%
10,517,221 $1.17 Billion
Q1 2022

May 11, 2022
BUY
$93.1 - $112.54 $453 Million - $547 Million
4,862,299 Added 730.98%
5,527,477 $614 Million
Q4 2021

Feb 08, 2022
BUY
$95.88 - $117.08 $17 Million - $20.7 Million
176,997 Added 36.26%
665,178 $74.5 Million
Q3 2021

Nov 09, 2021
BUY
$84.42 - $106.62 $10,299 - $13,007
122 Added 0.02%
488,181 $46.9 Million
Q2 2021

Aug 12, 2021
SELL
$67.66 - $84.76 $8,254 - $10,340
-122 Reduced 0.02%
488,059 $40.9 Million
Q1 2021

May 11, 2021
SELL
$67.06 - $75.82 $12 Million - $13.6 Million
-179,584 Reduced 26.89%
488,181 $32.9 Million
Q4 2020

Feb 05, 2021
SELL
$63.89 - $73.8 $21.8 Million - $25.1 Million
-340,595 Reduced 33.78%
667,765 $46.6 Million
Q3 2020

Nov 04, 2020
BUY
$63.69 - $70.22 $861,725 - $950,076
13,530 Added 1.36%
1,008,360 $70 Million
Q2 2020

Aug 06, 2020
SELL
$58.54 - $67.94 $9.24 Million - $10.7 Million
-157,780 Reduced 13.69%
994,830 $65.1 Million
Q1 2020

May 06, 2020
BUY
$49.46 - $64.78 $1 Million - $1.31 Million
20,276 Added 1.79%
1,152,610 $69.4 Million
Q4 2019

Feb 07, 2020
BUY
$49.86 - $58.26 $543,025 - $634,509
10,891 Added 0.97%
1,132,334 $65.5 Million
Q3 2019

Nov 08, 2019
SELL
$47.54 - $53.43 $5.16 Million - $5.8 Million
-108,543 Reduced 8.82%
1,121,443 $58 Million
Q2 2019

Aug 06, 2019
BUY
$46.79 - $52.47 $27.2 Million - $30.5 Million
580,944 Added 89.51%
1,229,986 $0
Q1 2019

May 10, 2019
BUY
$46.36 - $52.63 $30.1 Million - $34.2 Million
649,042 New
649,042 $34 Million

Others Institutions Holding NVO

# of Institutions
1,763
Shares Held
340M
Call Options Held
11.4M
Put Options Held
15.5M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $151B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email